Beyond The Bench - Research Highlights 2016

Director's Overview

At The University of Kansas Cancer Center, we look at cancer from several perspectives.

Early on, we recognized that in order to move closer towards a world without cancer, we first had to step back for a broader view, beyond the walls of our laboratories. From deepening our understanding of cancer’s biology to expanding cancer prevention efforts to ensuring patients’ care continues after treatment, we are tackling cancer on multiple fronts.

In these pages, we report on the progress we have made at the forefront of cancer research, including the development of new therapies. I’m excited for you to learn about a potential “first” for KU Cancer Center – a cancer drug discovered here in our laboratories, poised to become the first KU-invented cancer drug to go from bench to bedside entirely within the confines of our institution. We also discuss our sharpened focus on the underserved and minority populations, who all too often slip under the radar when it comes to prevention and early detection. Personalized medicine continues to be a vital component to our research. All of these and more demonstrate KU Cancer Center’s commitment to studying cancer from all aspects.

To enter full screen mode, click on the icon in the upper left corner.

A common thread throughout the report is the importance of collaboration across laboratories and institutions, including Stowers Institute for Medical Research and Children’s Mercy. By joining forces, patients benefit from a deeper pool of specialists and clinical trials, and researchers have access to a larger group of subject matter experts and other resources. Last year, KU Cancer Center and Children’s Mercy combined its pediatric oncology departments. With this partnership, all ages, from children to the elderly, are covered.

It’s an exciting time for KU Cancer Center and our community. We recently submitted our request for National Cancer Institute designation renewal, which is required every five years. In our application, we asked to be considered for Comprehensive designation, the most elite designation available to a cancer center. Comprehensive centers demonstrate an added depth and breadth of research, as well as substantial transdisciplinary research that bridges all scientific areas. It also requires a greater emphasis on preventing cancer through education, prevention and early detection. We have been working towards Comprehensive status for years, and it’s now within our reach.

I have been overwhelmed with the support KU Cancer Center has received from the community. Our supporters and donors have unfailingly been our biggest champions. In return, KU Cancer Center employees are giving back to the community, extending contributions beyond lab benches and clinics.

Without our researchers, scientists, clinicians and staff, our progress against cancer would come to a halt, but our team brings new insights and discoveries to the fight against cancer on a daily basis, and I am proud to share their work in this report. It is an honor to be surrounded by such an ambitious and committed group of people, all united in the quest to serve our patients and their families.

I hope you enjoy learning more about The University of Kansas Cancer Center.

Roy A. Jensen, M.D.
Director, The University of Kansas Cancer Center
Director, Kansas Masonic Cancer Research Institute

Previous Research Highlights  – 2016

Previous Research Highlights  – 2015

Previous Research Highlights  – 2014

Previous Research Highlights – 2013